Skip to main content
. 2022 Mar 31;10(2):e002745. doi: 10.1136/bmjdrc-2021-002745

Table 2.

Mortality and morbidity rates in the patient groups with and without atrial fibrillation

Events Incidence Unadjusted HR (95% CI) Adjusted HR (95% CI)†
n n/1000 PY
Cerebral cardiovascular events No AF 300 12.93 1.00 1.00
AF* 20 35.08 2.58 (1.64 to 4.08) 1.65 (1.03 to 2.66)
Stroke
No AF 160 6.67 1.00 1.00
AF 11 17.93 2.48 (1.34 to 4.60) 1.54 (0.81 to 2.93)
Coronary artery disease
No AF 155 6.52 1.00 1.00
AF 11 19.02 2.96 (1.59 to 5.50) 1.96 (1.03 to 3.73)
Heart failure
No AF 51 2.09 1.00 1.00
AF 12 20.03 15.11 (7.69 to 29.66) 5.17 (2.46 to 10.9)
All-cause death
No AF 437 17.80 1.00 1.00
AF 31 49.34 3.66 (2.53 to 5.30) 1.82 (1.24 to 2.67)
Ischemic stroke
No AF 110 4.56 1.00 1.00
AF 8 12.96 2.64 (1.28 to 5.45) 1.44 (0.68 to 3.07)
Hemorrhagic events
No AF 187 7.97 1.00 1.00
AF 8 12.94 1.58 (0.78 to 3.23) 1.34 (0.65 to 2.80)

*Number of patients: no AF (2403), AF (127).

†HRs obtained using a Cox proportional hazards model with adjustments for age, sex (men), body mass index (BMI), smoking history (current or past), presence/absence of hypertension and/or dyslipidemia, HbA1c, aspirin use, and duration of diabetes.

AF, atrial fibrillation; PY, person-years.